We are Sorry, This Page doesn't Exist
RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill Biopharma announces publication of results of Phase 3 study of Talicia
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen announces enrollment completion of Phase 3 STAR clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill Biopharma announces publication of results of Phase 3 study of RHB-102
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Applied Genetic announces completion of enrollment in Phase 1/2 XLRS study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill announces enrollment of 300th patient in Phase III TALICIA study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
EyePoint announces completion of enrollment of Phase 1 DAVIO trial of EYP-1901
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cue Biopharma announces interim clinical data on phase 1 study of CUE-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Can-Fite BioPharma announces 75% enrollment for Comfort study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MediWound announces enrollment of first patient in phase 2 study of EscharEx
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Longeveron announces completion of Phase I/II study of lomecel-b infusion
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Onconova announces enrollment in Phase 1 study with ON 123300 in China
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AzurRx announces completion of enrollment in Phase 2b OPTION 2 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Longeveron announces completion of Phase 1 study of lomecel-b injection
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eiger BioPharma announces results from Phase 2 PREVENT study of Avexitide
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Can-Fite BioPharma announces data from the Phase II advanced liver cancer study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill announces continuation of global Phase 2/3 study of opaganib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Strongbridge Biopharma completes enrollment in Phase 3 LOGICS study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Athersys announces enrollment of first patients in Phase 2/3 MultiStem study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»